PAK4 and cancer: This role is often altered in cancer cells, as a consequence of the activation of other pathways peculiar of transformed cells, such as the O-glycosylation (O-GlcNAc) pathway or the p21 Activated Kinase 4 (PAK4)-dependent activity.